Costly new breast cancer therapies augment the significant burden this disease places on healthcare resources, but in context they may still provide value to society.
Jeffrey M. Allen, PharmD, BCOP
Advertisement
Articles by Jeffrey M. Allen, PharmD, BCOP
Advertisement
Latest Updated Articles
- Economic/Societal Burden of Metastatic Breast Cancer: A US Perspective
Published: September 21st 2010 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
2
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
3
ESMO Congress Marks 50 Years by Showcasing the Future of Cancer Care: Vivek Subbiah, MD
4
Medical School Diversity Declines Following Affirmative Action Repeal
5
